Discover how PD-L2, the lesser-known immune checkpoint protein, plays a critical role in B-cell lymphoma and opens new avenues for cancer immunotherapy.
Explore how chromosomal alterations in Angioimmunoblastic T-Cell Lymphoma drive cancer development through TET2 and RHOA mutations.